
Amy Jo Sterling
Examiner (ID: 4242, Phone: (571)272-6823 , Office: P/3631 )
| Most Active Art Unit | 3631 |
| Art Unit(s) | 3632, 3631 |
| Total Applications | 2801 |
| Issued Applications | 2050 |
| Pending Applications | 118 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6689056
[patent_doc_number] => 20030032781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Differentiation-suppressive polypeptide'
[patent_app_type] => new
[patent_app_number] => 10/219247
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17704
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219247 | Differentiation-suppressive polypeptide | Aug 15, 2002 | Abandoned |
Array
(
[id] => 6765674
[patent_doc_number] => 20030100074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Methods and compositions for treating metabolic bone diseases relating to human endokine alpha'
[patent_app_type] => new
[patent_app_number] => 10/218547
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 100167
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100074.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218547 | Methods and compositions for treating metabolic bone diseases relating to human endokine alpha | Aug 14, 2002 | Issued |
Array
(
[id] => 6843098
[patent_doc_number] => 20030148445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'TALL-1 nucleic acid molecules, proteins, receptors and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/216074
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29573
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10216074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/216074 | TALL-1 nucleic acid molecules, proteins, receptors and methods of use thereof | Aug 8, 2002 | Abandoned |
Array
(
[id] => 6745855
[patent_doc_number] => 20030023038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Heterologous polypeptide of the TNF family'
[patent_app_type] => new
[patent_app_number] => 10/214065
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10425
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20030023038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10214065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/214065 | Heterologous polypeptide of the TNF family | Aug 6, 2002 | Issued |
Array
(
[id] => 6536322
[patent_doc_number] => 20020193309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'FGF9 as a specific ligand for FGFR3'
[patent_app_type] => new
[patent_app_number] => 10/212357
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4951
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212357 | FGF9 as a specific ligand for FGFR3 | Aug 1, 2002 | Abandoned |
Array
(
[id] => 6797009
[patent_doc_number] => 20030175883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'DNA encoding a mammalian LPA receptor and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/205911
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16394
[patent_no_of_claims] => 138
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205911 | DNA encoding a mammalian LPA receptor and uses thereof | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6839171
[patent_doc_number] => 20030036511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Analysis and separation of platelet-derived growth factor proteins'
[patent_app_type] => new
[patent_app_number] => 10/205693
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9894
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205693
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205693 | Analysis and separation of platelet-derived growth factor proteins | Jul 25, 2002 | Issued |
Array
(
[id] => 7394098
[patent_doc_number] => 20040038349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Heteromultimeric TNF ligand family members'
[patent_app_type] => new
[patent_app_number] => 10/202062
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 120619
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038349.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202062
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202062 | Heteromultimeric TNF ligand family members | Jul 24, 2002 | Abandoned |
Array
(
[id] => 6813388
[patent_doc_number] => 20030072938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Trans-lentiviral vector particles and transduction of eukaryotic cells therewith'
[patent_app_type] => new
[patent_app_number] => 10/202457
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6404
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072938.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202457 | Trans-lentiviral vector particles and transduction of eukaryotic cells therewith | Jul 23, 2002 | Issued |
Array
(
[id] => 7117388
[patent_doc_number] => 20050070689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Taci and br3 polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/485489
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 43423
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070689.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485489 | Taci and br3 polypeptides and uses thereof | Jul 23, 2002 | Abandoned |
Array
(
[id] => 6817784
[patent_doc_number] => 20030068742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/202410
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202410 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 22, 2002 | Abandoned |
Array
(
[id] => 6648593
[patent_doc_number] => 20030104550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/202413
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61087
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10202413
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202413 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 22, 2002 | Abandoned |
Array
(
[id] => 6817786
[patent_doc_number] => 20030068744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same '
[patent_app_type] => new
[patent_app_number] => 10/202474
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61087
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202474 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 22, 2002 | Abandoned |
Array
(
[id] => 6817774
[patent_doc_number] => 20030068732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/199673
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61105
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199673
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199673 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 17, 2002 | Abandoned |
Array
(
[id] => 6801190
[patent_doc_number] => 20030096355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family'
[patent_app_type] => new
[patent_app_number] => 10/193616
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 46379
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193616
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193616 | Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family | Jul 10, 2002 | Abandoned |
Array
(
[id] => 958897
[patent_doc_number] => 06953843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-11
[patent_title] => 'Antibodies and fragments thereof to MDL-1 protein'
[patent_app_type] => utility
[patent_app_number] => 10/191732
[patent_app_country] => US
[patent_app_date] => 2002-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31168
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/953/06953843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10191732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/191732 | Antibodies and fragments thereof to MDL-1 protein | Jul 7, 2002 | Issued |
Array
(
[id] => 6710454
[patent_doc_number] => 20030170203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Death domain containing receptors'
[patent_app_type] => new
[patent_app_number] => 10/189189
[patent_app_country] => US
[patent_app_date] => 2002-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 94060
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189189
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189189 | Death domain containing receptors | Jul 4, 2002 | Issued |
Array
(
[id] => 6682682
[patent_doc_number] => 20030118546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Antibodies to tumor necrosis factor 5'
[patent_app_type] => new
[patent_app_number] => 10/186643
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 83540
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10186643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/186643 | Antibodies to tumor necrosis factor 5 | Jul 1, 2002 | Abandoned |
Array
(
[id] => 6870027
[patent_doc_number] => 20030082716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/183003
[patent_app_country] => US
[patent_app_date] => 2002-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57325
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10183003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/183003 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 25, 2002 | Abandoned |
Array
(
[id] => 6648348
[patent_doc_number] => 20030104541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/183018
[patent_app_country] => US
[patent_app_date] => 2002-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10183018
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/183018 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 25, 2002 | Abandoned |